180 related articles for article (PubMed ID: 32475907)
1. IgG4-related Autoimmune Hepatitis with a Suspected Drug-induced Etiology.
Kawabata H; Kawakatsu Y; Inoue N; Okazaki Y; Sone D; Yamaguchi K; Ueda Y; Hitomi M; Miyata M; Motoi S; Enoki Y; Minamikawa T
Intern Med; 2020; 59(11):1401-1405. PubMed ID: 32475907
[TBL] [Abstract][Full Text] [Related]
2. [Recent progress in the diagnosis and therapy of autoimmune hepatitis].
Zenia M; Toda G
Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1763-7. PubMed ID: 10581761
[No Abstract] [Full Text] [Related]
3. Acute seronegative autoimmune hepatitis.
Ozaslan E; Samsar U; Erden E
Hepatogastroenterology; 2010; 57(98):334-5. PubMed ID: 20583438
[TBL] [Abstract][Full Text] [Related]
4. A case of primary biliary cholangitis overlapping with type 2 autoimmune hepatitis.
Amano N; Sato S; Murata A; Tsuzura H; Tomishima K; Sato S; Matsumoto K; Shimada Y; Iijima K; Harada K; Genda T
Clin J Gastroenterol; 2020 Feb; 13(1):79-82. PubMed ID: 31286423
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
6. IgG4-related Lung Pseudotumor and Pleural Inflammation with Autoimmune Hepatitis.
Nagashima K; Sano I; Kobayashi T; Eto K; Nagai K; Ninomiya R; Suzuki A; Oohata Y; Konishi K; Nakano T; Yamamoto F
Intern Med; 2018 Jan; 57(1):43-48. PubMed ID: 29033427
[TBL] [Abstract][Full Text] [Related]
7. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis.
Nakamura K; Yoneda M; Yokohama S; Tamori K; Sato Y; Aso K; Aoshima M; Hasegawa T; Makino I
J Gastroenterol Hepatol; 1998 May; 13(5):490-5. PubMed ID: 9641646
[TBL] [Abstract][Full Text] [Related]
9. Deep cholestatic jaundice as the predominant manifestation in autoimmune hepatitis.
Wang SB; Wang JH; Zheng RH; Zhong BH; Chen MH
Hepatogastroenterology; 2010; 57(98):326-9. PubMed ID: 20583436
[TBL] [Abstract][Full Text] [Related]
10. [A case of probable autoimmune hepatitis from which the persistence of hepatitis A IgM antibody, and the improvement was pathologically obtained by ursodeoxycholic acid medication].
Matsushita M; Takemura T; Imai Y; Takimoto K; Kuchide M; Kajikawa H; Kojima Y; Shimamoto F; Yamauchi H; Matsuyama K; Yoshikawa T
Nihon Shokakibyo Gakkai Zasshi; 2008 Sep; 105(9):1367-74. PubMed ID: 18772578
[TBL] [Abstract][Full Text] [Related]
11. Development of autoimmune hepatitis in primary biliary cirrhosis.
Gossard AA; Lindor KD
Liver Int; 2007 Oct; 27(8):1086-90. PubMed ID: 17845536
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune hepatitis in human immunodeficiency virus-infected patients: A case series and review of the literature.
Chaiteerakij R; Sanpawat A; Avihingsanon A; Treeprasertsuk S
World J Gastroenterol; 2019 Sep; 25(35):5388-5402. PubMed ID: 31558881
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome].
Zeng Z; Han YK; Zhang XF; Geng H
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune hepatitis in Japan: trends in a nationwide survey.
Takahashi A; Arinaga-Hino T; Ohira H; Torimura T; Zeniya M; Abe M; Yoshizawa K; Takaki A; Suzuki Y; Kang JH; Nakamoto N; Fujisawa T; Yonemoto K; Tanaka A; Takikawa H;
J Gastroenterol; 2017 May; 52(5):631-640. PubMed ID: 27722997
[TBL] [Abstract][Full Text] [Related]
15. [Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis].
Golovanova EV; Khomeriki SG; Petrakov AV; Serova TI
Eksp Klin Gastroenterol; 2010; (8):113-7. PubMed ID: 21268335
[No Abstract] [Full Text] [Related]
16. Immunoglobulin G4-associated autoimmune hepatitis with peripheral blood eosinophilia: a case report.
Chang A; Charoenlap C; Akarapatima K; Rattanasupar A; Prachayakul V
BMC Gastroenterol; 2020 Dec; 20(1):420. PubMed ID: 33308169
[TBL] [Abstract][Full Text] [Related]
17. Deflazacort for type-1 autoimmune hepatitis in a Korean girl.
Bae SH; Kim JS; Kim DH
J Korean Med Sci; 2006 Aug; 21(4):758-60. PubMed ID: 16891827
[TBL] [Abstract][Full Text] [Related]
18. Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids.
Duclos-Vallée JC; Di Martino V; Cazier A; Ballot E; Johanet C; Yamamoto AM; Emile JF; Guettier C; Coutarel P; Cadranel JF
Gastroenterol Clin Biol; 2005 Nov; 29(11):1173-6. PubMed ID: 16505766
[TBL] [Abstract][Full Text] [Related]
19. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
[TBL] [Abstract][Full Text] [Related]
20. Clinico-laboratory study on children with auto-immune hepatitis in Upper Egypt.
Abu Faddan NH; Abdel-Baky L; Aly SA; Rashed HA
Arab J Gastroenterol; 2011 Dec; 12(4):178-83. PubMed ID: 22305497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
